Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Jan 29;9(2):57.
doi: 10.3390/bioengineering9020057.

Impact of the Process Variables on the Yield of Mesenchymal Stromal Cells from Bone Marrow Aspirate Concentrate

Affiliations
Review

Impact of the Process Variables on the Yield of Mesenchymal Stromal Cells from Bone Marrow Aspirate Concentrate

Madhan Jeyaraman et al. Bioengineering (Basel). .

Abstract

Human bone marrow (BM) has been highlighted as a promising source of mesenchymal stromal cells (MSCs) containing various growth factors and cytokines that can be potentially utilized in regenerative procedures involving cartilage and bone. However, the proportion of MSCs in the nucleated cell population of BM is only around 0.001% to 0.01% thereby making the harvesting and processing technique crucial for obtaining optimal results upon its use in various regenerative processes. Although several studies in the literature have given encouraging results on the utility of BM aspiration concentrate (BMAC) in various regenerative procedures, there is a lack of consensus concerning the harvesting variables such as choice of anesthetic agent to be used, site of harvest, size of the syringe to be used, anticoagulant of choice, and processing variables such as centrifugation time, and speed. In this review article, we aim to discuss the variables in the harvesting and processing technique of BMAC and their impact on the yield of MSCs in the final concentrate obtained from them.

Keywords: bone marrow; bone marrow aspirate concentrate; mesenchymal stromal cells.

PubMed Disclaimer

Conflict of interest statement

The authors have declared that no competing interest exists.

Figures

Figure 1
Figure 1
Variables in the harvesting and process technique of bone marrow aspiration concentrate (BMAC).
Figure 2
Figure 2
Bone marrow aspirate concentrate preparation process.

Similar articles

Cited by

References

    1. Kim G.B., Seo M.-S., Park W.T., Lee G.W. Bone Marrow Aspirate Concentrate: Its Uses in Osteoarthritis. Int. J. Mol. Sci. 2020;21:3224. doi: 10.3390/ijms21093224. - DOI - PMC - PubMed
    1. Martin D.R., Cox N.R., Hathcock T.L., Niemeyer G.P., Baker H.J. Isolation and Characterization of Multipotential Mesenchymal Stem Cells from Feline Bone Marrow. Exp. Hematol. 2002;30:879–886. doi: 10.1016/S0301-472X(02)00864-0. - DOI - PubMed
    1. Chahla J., Dean C.S., Moatshe G., Pascual-Garrido C., Serra Cruz R., LaPrade R.F. Concentrated Bone Marrow Aspirate for the Treatment of Chondral Injuries and Osteoarthritis of the Knee: A Systematic Review of Outcomes. Orthop. J. Sports Med. 2016;4:2325967115625481. doi: 10.1177/2325967115625481. - DOI - PMC - PubMed
    1. Muschler G.F., Nitto H., Boehm C.A., Easley K.A. Age- and Gender-Related Changes in the Cellularity of Human Bone Marrow and the Prevalence of Osteoblastic Progenitors. J. Orthop. Res. 2001;19:117–125. doi: 10.1016/S0736-0266(00)00010-3. - DOI - PubMed
    1. Muschler G.F., Boehm C., Easley K. Aspiration to Obtain Osteoblast Progenitor Cells from Human Bone Marrow: The Influence of Aspiration Volume. J. Bone Joint Surg Am. 1997;79:1699–1709. doi: 10.2106/00004623-199711000-00012. - DOI - PubMed

LinkOut - more resources